Cloning of transporters for anionic drugs and the application to pharmacokinetic analysis

阴离子药物转运蛋白的克隆及其在药代动力学分析中的应用

基本信息

  • 批准号:
    11557005
  • 负责人:
  • 金额:
    $ 8.51万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2001
  • 项目状态:
    已结题

项目摘要

The purpose of this study is to identify new members of organic anion transporters of SLC22 family essential for the understanding of the pharmacokinetics of various drugs and xenobiotics. The final goal of this research is to establish the role of organic anion transporters in the pharmacokinetics by revealing the functions and tissue and cellular distribution of the human transporters. In the present study, we have identified six new members of the SLC22 family including OAT4 (organic anion transporter 4), OAT5, OAT6, OAT7, CT2 (carnitine transporter 2) and URAT1 (urate transporter 1). OAT4, OAT5 and OAT7 exhibit similar substrate selectivity preferring sulfate conjugates such as estrone sulgfate. OAT4 and OAT5 are present in the apical membrane of renal proximal tubules of human and rat, respectively. In contrast, OAT7 is present in the sinusoidal membrane of hepatocytes. Therefore, it is proposed that the sulfate conjugates formed in hepatocytes move into blood through OAT7 and taken up by renal proximal tubule epithelial cells via OAT1 and OAT3 on the basolateral membrane and excreted into urine via apical membrane OAT4 or OAT5. URAT1 is present in the apical membrane of renal proximal tubules and functions as an organic anion exchanger transporting urate, lactate, pyradine carboxylate and nicotinate. URAT 1 is responsible for the renal reabsorption of urate. Its genetic defect has turned out to be a cause of idiopathic renal hypouricemia. CT2 and OAT6 are carnitine transporters with different properties. It is notable that CT2 is expressed specifically in testis and is suggested to be important for sperm maturation. In addition, by generating cell lines stably expressing human organic anion transporters and analyzing the properties of the transport of various organic compounds using the cell lines, we have demonstrated that those cells lines are quite useful in the in vitro prediction of drug-drug interactions.
本研究的目的是鉴定 SLC22 家族有机阴离子转运蛋白的新成员,这对于了解各种药物和异生素的药代动力学至关重要。本研究的最终目标是通过揭示人体转运蛋白的功能以及组织和细胞分布来确定有机阴离子转运蛋白在药代动力学中的作用。在本研究中,我们鉴定了SLC22家族的六个新成员,包括OAT4(有机阴离子转运蛋白4)、OAT5、OAT6、OAT7、CT2(肉碱转运蛋白2)和URAT1(尿酸盐转运蛋白1)。 OAT4、OAT5 和 OAT7 表现出相似的底物选择性,更喜欢硫酸酯缀合物,例如硫酸雌酮。 OAT4和OAT5分别存在于人和大鼠肾近曲小管的顶膜中。相反,OAT7 存在于肝细胞的窦膜中。因此,推测肝细胞中形成的硫酸盐结合物通过OAT7进入血液,并通过基底外侧膜上的OAT1和OAT3被肾近曲小管上皮细胞摄取,并通过顶膜OAT4或OAT5排泄到尿液中。 URAT1 存在于肾近曲小管的顶膜中,充当运输尿酸盐、乳酸、吡啶羧酸盐和烟酸盐的有机阴离子交换剂。 URAT 1 负责肾脏对尿酸盐的重吸收。其遗传缺陷已被证明是特发性肾性低尿酸血症的原因。 CT2 和 OAT6 是具有不同特性的肉碱转运蛋白。值得注意的是,CT2 在睾丸中特异性表达,并且被认为对精子成熟很重要。此外,通过生成稳定表达人类有机阴离子转运蛋白的细胞系并使用细胞系分析各种有机化合物的转运特性,我们已经证明这些细胞系在药物-药物相互作用的体外预测中非常有用。

项目成果

期刊论文数量(206)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sekine, T., Seok Ho Cha, Kanai, Y. and Endou, H.: "Molecular biology of multispecific organic anion transporter family (OAT family)"Clin. Exp. Nephrol.. 3. 237-243 (1999)
Sekine, T.、Seok Ho Cha、Kanai, Y. 和 Endou, H.:“多特异性有机阴离子转运蛋白家族(OAT 家族)的分子生物学”Clin。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kageyama, T: "The 4F2hc/LAT 1 complex transporters L-DOPA across the blood-brain barrier"Brain Res.. 879. 115-121 (2000)
Kageyama, T:“跨越血脑屏障的 4F2hc/LAT 1 复合转运蛋白 L-DOPA”Brain Res.. 879. 115-121 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sekine, T: "The multispecific organic anion transporter (OAT) family"Pflugers Arch.. 440. 337-350 (2000)
Sekine, T:“多特异性有机阴离子转运蛋白 (OAT) 家族”Pflugers Arch.. 440. 337-350 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Jariyawat, S.: "The interaction and transport of b-lactam antibiotics with the cloned rat organic anion organic anion transporter 1"J.Pharmacol.Exp.Ther.. 290. 672-677 (1999)
Jariyawat, S.:“β-内酰胺抗生素与克隆的大鼠有机阴离子有机阴离子转运蛋白 1 的相互作用和转运”J.Pharmacol.Exp.Ther.. 290. 672-677 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KANAI Yoshikatsu其他文献

KANAI Yoshikatsu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KANAI Yoshikatsu', 18)}}的其他基金

Regulation of cellular metabolism and functions mediated by amino acid transporters and the mechanisms of action of their inhibitors
氨基酸转运蛋白介导的细胞代谢和功能调节及其抑制剂的作用机制
  • 批准号:
    15H04685
  • 财政年份:
    2015
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of plasma membrane leucine receptor and elucidation of its link to mTOR signaling pathway
质膜亮氨酸受体的鉴定及其与 mTOR 信号通路的联系的阐明
  • 批准号:
    24659116
  • 财政年份:
    2012
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Signaling mechanisms of a novel-type transmembrane receptor 4F2hc
新型跨膜受体4F2hc的信号传导机制
  • 批准号:
    22659052
  • 财政年份:
    2010
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Roles of a novel kidney-specific prostaglandin(PG) transporter in local PG clearance in renal cortex and its pathological relevance
新型肾脏特异性前列腺素(PG)转运蛋白在肾皮质局部 PG 清除中的作用及其病理相关性
  • 批准号:
    21390264
  • 财政年份:
    2009
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification and functional characterization of plasma membrane amino acid sensors
质膜氨基酸传感器的鉴定和功能表征
  • 批准号:
    19590256
  • 财政年份:
    2007
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on_the protein-protein interaction regulating the function of amino acid transporters
蛋白质-蛋白质相互作用调节氨基酸转运蛋白功能的研究
  • 批准号:
    17590226
  • 财政年份:
    2005
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Organic solute transportsomes: their molecular assembly and functional significance
有机溶质转运体:它们的分子组装和功能意义
  • 批准号:
    17081016
  • 财政年份:
    2005
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Transportsome on biomembrane systems: its molecular assembly and physiological function.
生物膜系统上的转运体:其分子组装和生理功能。
  • 批准号:
    17081015
  • 财政年份:
    2005
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Identification and functional characterization of all the genes of heterodimeric amino acid transporter family by means of whole genome information
利用全基因组信息对异二聚体氨基酸转运蛋白家族所有基因进行鉴定和功能表征
  • 批准号:
    14570085
  • 财政年份:
    2002
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of drug transports via amino acid transporters
通过氨基酸转运蛋白转运药物的分子机制
  • 批准号:
    12670095
  • 财政年份:
    2000
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

A multiscale structural understanding of organic anion transporting polypeptide transporters (OATPs) functions
对有机阴离子转运多肽转运蛋白 (OATP) 功能的多尺度结构理解
  • 批准号:
    RGPIN-2021-03486
  • 财政年份:
    2022
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Discovery Grants Program - Individual
A multiscale structural understanding of organic anion transporting polypeptide transporters (OATPs) functions
对有机阴离子转运多肽转运蛋白 (OATP) 功能的多尺度结构理解
  • 批准号:
    DGECR-2021-00185
  • 财政年份:
    2021
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Discovery Launch Supplement
Organic Anion Transporting Polypeptide (OATP), P-glycoprotein (P-gp), and Breast Cancer Resistance Protein (BCRP) transporters modulate tamoxifen response during breast cancer therapy
有机阴离子转运多肽 (OATP)、P-糖蛋白 (P-gp) 和乳腺癌抗性蛋白 (BCRP) 转运蛋白在乳腺癌治疗期间调节他莫昔芬反应
  • 批准号:
    452037
  • 财政年份:
    2021
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Operating Grants
A multiscale structural understanding of organic anion transporting polypeptide transporters (OATPs) functions
对有机阴离子转运多肽转运蛋白 (OATP) 功能的多尺度结构理解
  • 批准号:
    RGPIN-2021-03486
  • 财政年份:
    2021
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Discovery Grants Program - Individual
Expression of organic anion transporter after massive hepatectomy for liver impairment
肝损伤大面积肝切除术后有机阴离子转运蛋白的表达
  • 批准号:
    20K09001
  • 财政年份:
    2020
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of the renal organic anion transporter OAT1 in metabolism and physiology
肾脏有机阴离子转运蛋白 OAT1 在代谢和生理学中的作用
  • 批准号:
    10408067
  • 财政年份:
    2019
  • 资助金额:
    $ 8.51万
  • 项目类别:
Functional elucidation of an organic anion transporter which is overexpressed in undernutrition condition during fetus development.
胎儿发育期间营养不良条件下过度表达的有机阴离子转运蛋白的功能阐明。
  • 批准号:
    19K08274
  • 财政年份:
    2019
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of the renal organic anion transporter OAT1 in metabolism and physiology
肾脏有机阴离子转运蛋白 OAT1 在代谢和生理学中的作用
  • 批准号:
    10179427
  • 财政年份:
    2019
  • 资助金额:
    $ 8.51万
  • 项目类别:
Role of the renal organic anion transporter OAT1 in metabolism and physiology
肾脏有机阴离子转运蛋白 OAT1 在代谢和生理学中的作用
  • 批准号:
    10645329
  • 财政年份:
    2019
  • 资助金额:
    $ 8.51万
  • 项目类别:
Role of the renal organic anion transporter OAT1 in metabolism and physiology
肾脏有机阴离子转运蛋白 OAT1 在代谢和生理学中的作用
  • 批准号:
    10224587
  • 财政年份:
    2019
  • 资助金额:
    $ 8.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了